Engineering of Amphiphilic Erlotinib Analogue as Novel Nanomedicine for Non-Small Cell Lung Cancer Therapy

PURPOSE: Molecular targeted therapy is one of the most pivotal strategies in the treatment of non-small cell lung cancer, yet its curative effect is severely compromised by the poor aqueous solubility, low bioavailability and inadequate tumor accumulation of targeted agents. To enhance the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Mei, Pang, Houjun, Xie, Guangxing, Li, Feifei, Li, Chunxiao, Sun, Hao, Yang, Shaoyou, Zhao, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638928/
https://www.ncbi.nlm.nih.gov/pubmed/37954452
http://dx.doi.org/10.2147/IJN.S432464

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638928/
https://www.ncbi.nlm.nih.gov/pubmed/37954452
http://dx.doi.org/10.2147/IJN.S432464

Ejemplares similares